The potential role of gut microbial products is one of the most highlighted issues in nonalcoholic steatohepatitis (NASH) and type 2 diabetes. Gut dysbiosis and
Viral hepatitis is a major cause of death worldwide (1). Despite considerable morbidity and mortality associated with hepatitis B and hepatitis C globally, ther